Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2021-08-06 00:00:00 ET · period of report 2021-08-05 · accession 0001708138-21-000043 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-06 | 2021-08-05 | REGN | Bassler Bonnie L | Dir | M - OptEx | $391.92 | +2,559 | 3,450 | +287% | +$1.00M |
| D | 2021-08-06 | 2021-08-05 | REGN | Bassler Bonnie L | Dir | S - Sale+OE | $600.00 | -2,559 | 891 | -74% | -$1.54M |
| D | 2021-08-06 | 2021-08-05 | REGN | Bassler Bonnie L | Dir | M - OptEx | $0.00 | -2,559 | 5,118 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-05 | M | A | 2,559 | $391.92 | 3,450 | D | — | — | |
| 2 | Common | Common Stock | 2021-08-05 | S | D | 2,559 | $600.00 | 891 | D | — | — | |
| 3 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-08-05 | M | D | 2,559 | $0.00 | 5,118 | D | $391.92 · — to 2026-09-09 | 2,559 Common Stock | (F2) The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant. |